Iscib1+, Nivolumab & Ipilimumab, Yervoy, Opdivo
Skin Cancer, Metastatic Melanoma, Advanced Melanoma, Melanoma (Skin Cancer)
Phase III
Not Yet Recruiting
iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma
Sep 03, 2026
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Scancell Holdings PLC (SCP) have in its pipeline
SCP is currently developing the following drugs: Iscib1+, Nivolumab & Ipilimumab, Yervoy, Opdivo, Pembrolizumab, Modi-1 Moditope, Micronjet600 Microneedle Device, Scib1 Or Iscib1+ Dna Vaccine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.